NuView, Otsuka Team up to Develop, Commercialize Biomarker for Breast, Prostate Cancer | GenomeWeb

NEW YORK (GenomeWeb) – NuView Life Sciences and Otsuka Pharmaceutical said today they have reached a global licensing and collaboration deal to further develop and commercialize NuView's genomic-based diagnostic biomarker for detecting breast and prostate cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.